Ukraine Updates
We are adapting our strategy for conducting clinical trials in response to the challenges posed by the war in Ukraine, building on the lessons learned from our experience during the COVID-19 pandemic.
General Inquiries
PrioritizingPatient Interests
We prioritize the well-being and interests of patients already enrolled in the trial, taking into account ethical, medical, and methodological considerations for the trial’s ongoing conduct and feasibility.
It is recommended to seek scientific advice early in the process of significant changes to the current protocol or trial design are deemed necessary.
We ensure accessibility to clinical trial data through online channels, from the initiation to the completion of treatment, while implementing measures to prevent participant unblinding. This requires the establishment of processes to secure data, incorporating data provenance, privacy protection, traceability, and auditability.
Furthermore, providing emergency contact details to patients displaced by the war is crucial, ensuring they can access necessary care during these challenging times.
Interested in receiving a proposal from ClinicalTrialsUA? How you choose to get in touch depends on your query type
You are not CRO,
investigator or patient?
If you have another type of inquiry, please
click here
For CRO & Sponsors
Interested in ClinicalTrialsUA SMO's network, principal investigators, and capabilities?
For investigators | PI | Sites
We are looking for physicians, clinics, health systems or other research organizations that want to develop a strategic partnership offering clinical research as a care option for patients.
For patients
Patient care is at the heart of everything we do, and we are committed to ensuring you are treated with the utmost care and respect whilst maintaining the highest standard of research.